Table 2.
LncRNA | Tumour type | Expression | Interaction with Hippo cascade | Biological function in cancers | Ref. |
---|---|---|---|---|---|
BCAR4 | BC | ↑ | YAP promotes BCAR4 expression | Glycolysis | 26 |
CYTOR (LINC00152) | CRC | ↑ | YAP increases CYTOR expression, which in turn sponges to miR‐632 and miR‐185‐3p to target FSCN1 | Proliferation, invasion, metastasis | 51 |
H19 | Osteosarcoma, bladder cancer | ↑ | YAP increases H19 expression | Proliferation, migration | 53, 90 |
MT1DP | Liver cancer | ↓ | YAP and Runx2 inhibit MT1DP expression dependent on FoxA1 | Proliferation, apoptosis, colony formation | 47 |
NORAD | Lung and breast cancer metastasis | ↓ | YAP/TAZ‐TEAD and NuRD complex repress NORAD expression | Migration and invasion | 52 |
Abbreviations: ↑ upregulated; ↓ downregulated; BC, breast cancer; BCAR4, breast cancer antiestrogen resistance 4; CRC, colorectal cancer; CYTOR, cytoskeleton regulator RNA; FSCN1, fascin actin‐binding protein 1; MT1DP, metallothionein 1D, pseudogene; NORAD, non‐coding RNA activated by DNA damage; TAZ, transcriptional co‐activator with PDZ‐binding motif; TEAD, transcriptional enhancer‐associated domain; YAP, yes‐associated protein.